Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline vs azithromycin for refractory Mycoplasma pneumonia in children over 8 years
ChiCTR2000038463Phase 4Recruiting
- Sponsor
- Affiliated Children's Hospital, Capital Institute of Pediatrics
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of azithromycin and minocycline in Mycoplasmal pneumonia (2 arms), sponsored by Affiliated Children's Hospital, Capital Institute of Pediatrics. Primary endpoint: Mycoplasma pneumoniae RNA copy number. Started Nov 2020; status: recruiting.
02
Drugs
azithromycinminocycline
03
Conditions
Mycoplasmal pneumonia
Beyond the preview
Go deeper on ChiCTR2000038463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038463.